Navigation Links
Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
Date:10/25/2012

NEW YORK, Oct. 25, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of PSS World Medical, Inc. ("PSS World Medical" or the "Company") (Nasdaq: PSSI) concerning the proposed acquisition of the Company by McKesson Corporation ("McKesson") in a cash and debt transaction valued at approximately $2.1 billion. 

(Logo:  http://photos.prnewswire.com/prnh/20120215/MM54604LOGO)

On October 25, 2012, PSS World Medical and McKesson announced that they have entered into a definitive agreement providing for McKesson to acquire PSS World Medical for $2.1 billion (including the assumption of debt). Under the terms of the merger agreement, PSS World Medical shareholders will receive $29.00 per share in cash.

The firm's investigation concerns whether PSS World Medical's board of directors breached its fiduciary duties by failing to adequately solicit competing bidders for the Company and obtaining the best possible value for PSS World Medical's shareholders before entering into an agreement with McKesson.

If you own PSS World Medical shares and wish to discuss your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Christopher J. Safrath
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212) 935-7400
Email: csafrath@hfesq.com
Website: http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising© 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
2. Compass Diversified Holdings Announces Third Quarter 2012 Earnings and Conference Call Information
3. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
4. Access Pharmaceuticals Announces Private Placement Financing
5. Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinsons Disease
6. Call for Submissions: ICAP Patent Brokerage Announces Expansion of Life Sciences Practice and Increased Buyer Interest in Related Intellectual Property
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
8. Actinium Pharmaceuticals Announces New Round of Financing
9. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
10. Cyberonics Announces Investment In cerbomed GmbH
11. ULURU Inc. Announces First Order Of Altrazeal For European Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million people ... from the epidemic of diabetes. 1 However, nearly ... elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... complications, including cardiovascular events. If left untreated, hyperglycemia can ... eye disease or blindness. 3 As ...
(Date:12/6/2016)... -- With opioids commonly used for pain management for workplace injuries, ... has led to nationwide fatalities. The synthetic opioid called ... heroin or morphine, resulting in likelihood of addiction, abuse or death. ... , , ... Behavioral Health for HMC HealthWorks, explained the opioid drug is less ...
(Date:12/6/2016)... -- Blueprint Medicines Corporation (NASDAQ: BPMC ), a ... patients with genomically defined diseases, today announced that it ... in shares of its common stock. In addition, Blueprint ... to purchase up to an additional of $18,750,000 million ... the public offering. All shares of common stock will ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... The ... offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington ... needs treatment for a brain tumor. , Jason Bauer and his family are ...
(Date:12/7/2016)... Queens, NY (PRWEB) , ... December 07, 2016 , ... ... to business owners and families throughout the Five Boroughs, is launching a charity drive ... League works to continue the traditions and spirit of marines and Navy FMF Corpsmen. ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Delete® - ... in Time For The Holiday Party Season. Save Up To 33% Off Botox® and ... Salon is providing the Phoenix Valley with Delightful Deals on Botox® and ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... ... ... “Walking With God: Inspirational Lessons from My Life's Journey”: a sometimes ... of God's direction in their lives. “Walking With God: Inspirational Lessons from My Life's ... leader. , Sanford says, “I enjoy sharing the true stories in my ...
Breaking Medicine News(10 mins):